GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » Dividend-Payout-to-FFO

Guangdong Hybribio Biotech Co (SZSE:300639) Dividend-Payout-to-FFO


View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Guangdong Hybribio Biotech Co (SZSE:300639) Business Description

Traded in Other Exchanges
N/A
Address
D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000
Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.